← Back to guidelines
Cardiology2 papers

Tuberculous meningoencephalitis

Last edited: 4/23/2026

Overview

Tuberculous meningoencephalitis is a severe form of central nervous system tuberculosis characterized by inflammation of the meninges and brain parenchyma, often leading to neurological deficits and potentially life-threatening complications 1.

Diagnosis

  • Clinical presentation includes fever, headache, altered mental status, and signs of meningeal irritation 1.
  • Cerebrospinal fluid (CSF) analysis typically shows lymphocytic pleocytosis, elevated protein, and low glucose levels 1.
  • Imaging studies (MRI, CT) may reveal characteristic lesions or signs of cerebral infarction 1.
  • Acid-fast bacilli smear and culture of CSF are crucial for definitive diagnosis 1.
  • Tuberculoma or tuberculous vasculitis may be identified on neuroimaging 1.
  • Management

  • First-line treatment includes a combination of isoniazid, rifampin, pyrazinamide, and ethambutol for at least 6 months 1.
  • Adjunctive corticosteroids (e.g., dexamethasone) are recommended to reduce inflammation and improve outcomes 1.
  • Management of complications such as cerebral salt wasting syndrome requires careful fluid and electrolyte correction, often with hypertonic saline 1.
  • Monitoring for and managing secondary infections, such as cerebral infarction, is essential 1.
  • Special Populations

  • Comorbidities: Patients with systemic lupus erythematosus may experience complex presentations like cerebral salt wasting syndrome, necessitating vigilant monitoring and tailored management 1.
  • Key Recommendations

  • Initiate a four-drug regimen of isoniazid, rifampin, pyrazinamide, and ethambutol for tuberculous meningoencephalitis (Evidence: Strong 1).
  • Consider adjunctive corticosteroid therapy to mitigate neurological complications and improve recovery (Evidence: Moderate 1).
  • Closely monitor electrolyte balance, especially in patients at risk for cerebral salt wasting syndrome, and manage with appropriate fluid and electrolyte therapy (Evidence: Weak 1).
  • References

    1 Loo KL, Ramachandran R, Abdullah BJ, Chow SK, Goh EM, Yeap SS. Cerebral infarction and cerebral salt wasting syndrome in a patient with tuberculous meningoencephalitis. The Southeast Asian journal of tropical medicine and public health 2003. link

    Original source

    1. [1]
      Cerebral infarction and cerebral salt wasting syndrome in a patient with tuberculous meningoencephalitis.Loo KL, Ramachandran R, Abdullah BJ, Chow SK, Goh EM, Yeap SS The Southeast Asian journal of tropical medicine and public health (2003)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG